美邦股份(605033) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 289.41 million, a decrease of 7.27% compared to CNY 312.09 million in the same period last year[3]. - Net profit attributable to shareholders decreased by 32.60% to CNY 29.95 million from CNY 44.44 million year-on-year[3]. - The basic and diluted earnings per share both fell by 32.60% to CNY 0.22 from CNY 0.33 in the previous year[3]. - Operating profit for Q1 2025 was CNY 29,978,062.51, down 39.5% from CNY 49,551,153.96 in Q1 2024[18]. - Net profit for Q1 2025 was CNY 29,952,315.41, a decline of 32.5% from CNY 44,438,201.38 in Q1 2024[19]. - Total operating revenue for Q1 2025 was CNY 289,411,865.67, a decrease of 7.2% compared to CNY 312,087,364.29 in Q1 2024[17]. - Total operating costs for Q1 2025 were CNY 254,282,718.83, down 3.1% from CNY 262,951,889.71 in Q1 2024[17]. Cash Flow - The net cash flow from operating activities was negative at CNY -109.90 million, a decline of 407.61% compared to CNY -21.65 million in the same period last year[3]. - Cash flow from operating activities for Q1 2025 was negative CNY 109,895,800.85, compared to negative CNY 21,649,662.18 in Q1 2024[22]. - Cash inflow from investment activities in Q1 2025 was CNY 555,628,784.20, an increase from CNY 393,671,078.58 in Q1 2024[22]. - Cash flow from investment activities generated a net cash inflow of CNY 81,495,798.56 in Q1 2025, compared to a net outflow of CNY 233,645,850.90 in Q1 2024[22]. - The net cash flow from financing activities was -$29,921,421.24, compared to -$12,551,195.84 in the previous period[23]. - The total cash outflow from financing activities amounted to $40,002,873.29, while the previous period recorded $14,944,895.84[23]. - The net increase in cash and cash equivalents was -$58,321,423.53, compared to -$267,846,708.92 in the previous period[23]. - The ending balance of cash and cash equivalents was $161,893,414.27, down from $184,583,918.19 in the previous period[23]. - The beginning balance of cash and cash equivalents was $220,214,837.80, compared to $452,430,627.11 in the previous period[23]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1.83 billion, reflecting a decrease of 1.58% from the previous year-end[4]. - Current assets totaled RMB 998,872,373.16, down from RMB 1,096,712,579.53 at the end of 2024, indicating a decline of approximately 8.9%[12]. - Cash and cash equivalents were reported at RMB 239,462,942.65, a decrease from RMB 267,862,944.94 at the end of 2024, reflecting a decline of about 10.6%[11]. - Total liabilities amounted to CNY 678,014,704.98, a decrease from CNY 737,371,303.60 in the previous period[14]. - Total current liabilities were RMB 492,785,882.85, down from RMB 616,258,330.47, indicating a reduction of approximately 20.0%[13]. - Long-term borrowings remained stable at RMB 72,000,000.00, unchanged from the previous period[13]. - The company reported a significant increase in expected liabilities, rising to RMB 105,497,998.29 from RMB 41,257,474.88, an increase of approximately 156.0%[13]. Accounts Receivable and Inventory - The company reported a significant increase in accounts receivable by 191.03%, primarily due to the timing of business annual payment settlements[6]. - Accounts receivable increased to RMB 168,042,468.95 from RMB 57,741,288.18, showing a significant rise of approximately 191.5%[12]. - Inventory decreased to RMB 225,828,602.43 from RMB 264,714,237.77, representing a decline of about 14.7%[12]. Other Financial Metrics - The return on equity (ROE) decreased to 2.63%, down by 1.28 percentage points from 3.91% in the previous year[3]. - The company recorded a total of CNY 2.23 million in non-recurring gains and losses, after accounting for tax effects[5]. - Total equity attributable to shareholders was CNY 1,154,613,299.98, an increase from CNY 1,124,660,984.57 in the previous period[14]. - The total equity of the company is not explicitly stated but can be inferred from the total assets and liabilities[13]. Business Developments - The company has not disclosed any new product developments or market expansion strategies during this reporting period[10].